Edgewise TherapeuticsEWTX
那斯達克 · USD
14.31
+0.05
(+0.35%)
收盤 08/02 03:59 (UTC+8)
盤後
0
0
(0%)
08/02 03:59 (UTC+8)
Edgewise TherapeuticsEWTX
14.31
+0.05
(+0.35%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | - | - | - | - | - | 33,862 | 29,452 | 25,339 | 25,704 | 22,079 |
研發費用 | 36,757 | 36,370 | 32,222 | 30,680 | 27,694 | 27,684 | 23,786 | 19,559 | 19,876 | 16,612 |
推銷及管理費用 | 9,202 | 9,170 | 8,210 | 7,427 | 7,059 | 6,178 | 5,666 | 5,780 | 5,828 | 5,467 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -45,959 | -45,540 | -40,432 | -38,107 | -34,753 | -33,862 | -29,452 | -25,339 | -25,704 | -22,079 |
其他收入及費用 | 5,161 | 5,878 | 6,303 | 6,610 | 6,228 | 3,719 | 3,739 | 3,870 | 2,866 | 2,664 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -40,798 | -39,662 | -34,129 | -31,497 | -28,525 | -30,143 | -25,713 | -21,469 | -22,838 | -19,415 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -40,798 | -39,662 | -34,129 | -31,497 | -28,525 | -30,143 | -25,713 | -21,469 | -22,838 | -19,415 |
基本每股稅後盈餘(元) | -0.43 | -0.42 | -0.36 | -0.34 | -0.33 | - | -0.41 | -0.34 | -0.36 | -0.30 |
稀釋每股稅後盈餘(元) | -0.43 | -0.42 | -0.37 | -0.33 | -0.33 | -0.47 | -0.40 | -0.34 | -0.36 | -0.30 |
基本平均股數(千股) | 95130.00 | 94763.00 | 93813.00 | 93515.00 | 87567.00 | - | 63459.00 | 63380.00 | 63265.00 | 63337.00 |
稀釋平均股數(千股) | 95130.00 | 94763.00 | 93813.00 | 93515.00 | 87567.00 | - | 63459.00 | 63380.00 | 63265.00 | 63337.00 |
還原基本每股稅後盈餘(元) | -0.43 | -0.42 | -0.36 | -0.34 | -0.33 | - | -0.41 | -0.34 | -0.36 | -0.30 |
還原稀釋每股稅後盈餘(元) | -0.43 | -0.42 | -0.37 | -0.33 | -0.33 | -0.47 | -0.40 | -0.34 | -0.36 | -0.30 |
還原基本平均股數(千股) | 95,130 | 94,763 | 93,813 | 93,515 | 87,567 | - | 63,459 | 63,380 | 63,265 | 63,337 |
還原稀釋平均股數(千股) | 95,130 | 94,763 | 93,813 | 93,515 | 87,567 | - | 63,459 | 63,380 | 63,265 | 63,337 |
EBITDA(千元) | -42,167 | -41,635 | -36,767 | -34,516 | -31,150 | -31,782 | -27,591 | -23,903 | -24,672 | -21,078 |